The effectiveness of dual therapy employing PRI-724 was also evaluated by Osawa et al., who indicated that PRI-724 combined with an anti-PD-L1 antibody resulted in tumor regression in a mouse model of colon cancer liver metastasis. Here, CD274 is linked to neoplasm.